Akouos Raises $50 Million Series A Financing and Expands Team toAdvance Precision Genetic Therapies That Restore and Preserve HearingCompany expands leadership team, board of directors and launchesscientific advisory board with leading scientists and physicians in thehearing and gene therapy fields BOSTON, August 7, 2018-- Akouos,a precision genetic medicine company developing gene therapies thatrestore and preserve hearing, today announced the Company has raised $50million in Series A financing. Seed investors 5AM Ventures and NewEnterprise Associates (NEA) co-led the round, and were joined byexisting seed investor Partners Innovation Fund and new investorsSofinnova Ventures, RA Capital Management and Novartis Venture Fund.